12/19/2007

Eli Lilly and Co. is seeking FDA approval for a long-acting form of its best-selling schizophrenia and bipolar disorder drug, Zyprexa. The new version would be an injection administered every two or four weeks in a doctor's office.

Full Story:
Bloomberg, CNNMoney

Related Summaries